Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 08/15/2025 | CALL | $800.00 | 1,820 | +1,820 | |
| 08/15/2025 | PUT | $800.00 | 1,820 | +1,820 | |
| 08/15/2025 | PUT | $655.00 | 1,583 | +1,143 | +259.77% |
| 08/22/2025 | CALL | $720.00 | 1,244 | +1,033 | +489.57% |
| 09/26/2025 | CALL | $740.00 | 1,026 | +1,007 | +5,300.00% |
| 09/26/2025 | CALL | $720.00 | 1,012 | +1,003 | +11,144.44% |
| 08/15/2025 | CALL | $665.00 | 166 | -870 | -83.98% |
| 08/15/2025 | CALL | $645.00 | 8 | -878 | -99.10% |
| 08/15/2025 | CALL | $670.00 | 600 | -913 | -60.34% |
| 08/15/2025 | CALL | $655.00 | 48 | -941 | -95.15% |
| 08/15/2025 | CALL | $660.00 | 73 | -1,611 | -95.67% |
| 08/15/2025 | CALL | $650.00 | 409 | -2,230 | -84.50% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.74% | 26M | 11.45B |
| Vanguard 500 Index Fund | 1.92% | 18.23M | 8.03B |
| Vanguard/Primecap Fund | 1.56% | 14.85M | 6.54B |
| Fidelity 500 Index Fund | 0.91% | 8.65M | 3.81B |
| SPDR S&P 500 ETF Trust | 0.90% | 8.54M | 3.76B |
| Vanguard Specialized-Health Care Fund | 0.80% | 7.64M | 3.37B |
| iShares Core S&P 500 ETF | 0.74% | 7.04M | 3.1B |
| Washington Mutual Investors Fund | 0.73% | 6.95M | 3.06B |
| Growth Fund Of America Inc | 0.71% | 6.7M | 2.95B |
| Select Sector SPDR Fund-Health Care | 0.67% | 6.41M | 2.82B |
Why Novo Nordisk Flew Almost 3% Higher on Friday
08/15 05:15 pm
The Motley Fool
Read moreEli Lilly To Raise Mounjaro Price In UK, Expands Obesity Drug Push In India
08/14 11:11 am
Benzinga
Read moreLeap Therapeutics Slashes R&D Spending
08/14 07:23 am
The Motley Fool
Read moreSEED Therapeutics Named Finalist for 2025 Prix Galien USA “Best Start-Up” Award
08/14 07:00 am
GlobeNewswire Inc.
Read moreWhy Eli Lilly Stock Popped Today
08/13 03:20 pm
The Motley Fool
Read moreTexas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound
08/13 08:15 am
Benzinga
Read moreHims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now
08/12 12:32 pm
Benzinga
Read moreIf You'd Invested $1,000 in Viking Therapeutics 3 Years Ago, Here's How Much You'd Have Today
08/12 10:26 am
The Motley Fool
Read moreWhy Novo Nordisk Stock Flew Higher on Friday
08/08 07:00 pm
The Motley Fool
Read moreWhy Eli Lilly Stock Sank 18% This Week
08/08 05:25 pm
The Motley Fool
Read moreEli Lilly's Orforglipron Data Is Not Disastrous: Analyst
08/08 02:06 pm
Benzinga
Read moreSitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following portfolio reprioritization
08/08 12:00 pm
GlobeNewswire Inc.
Read moreApple Jumps, Eli Lilly Crashes On Worst Day In 25 Years: What's Moving Markets Thursday?
08/07 01:37 pm
Benzinga
Read moreNasdaq 100 Eyes New Highs on Geopolitical Optimism, Tech Relief and Rate Cut Bets
08/07 09:42 am
Investing.com
Read moreEli Lily Q2 Earnings Preview: Future Depends on Mounjaro and Zepbound Performance
08/07 02:37 am
Investing.com
Read moreWhy Novo Nordisk Stock Slipped Today
08/06 06:23 pm
The Motley Fool
Read moreIs It Time to Buy Biotech Stocks?
08/06 04:28 pm
The Motley Fool
Read moreRigel (RIGL) Q2 Revenue Jumps 176%
08/06 07:19 am
The Motley Fool
Read moreNxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management
08/05 07:30 pm
GlobeNewswire Inc.
Read moreWhy Novo Nordisk Stock Is Down Again Today
08/05 01:22 pm
The Motley Fool
Read moreNovo Nordisk Stock Sinks—But Is a Bottom Finally In?
08/05 10:11 am
Investing.com
Read moreFoghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update
08/05 07:00 am
GlobeNewswire Inc.
Read moreAlzheimer's Disease Disease-Modifying Therapies Markets, 2023-2025 & 2026-2030 | Key Marketed Products, Clinical Trials, Competitive Scenario and R&D Activities
08/05 04:26 am
GlobeNewswire Inc.
Read morePrediction: This Unstoppable Growth Stock Will Be Worth $2 Trillion in the Next 7 Years
08/04 08:33 pm
The Motley Fool
Read moreThis Biotech Stock Could Soar on Upcoming Clinical Data
08/04 07:15 am
The Motley Fool
Read moreWhy Novo Nordisk Stock Bumped Higher on Friday
08/01 05:26 pm
The Motley Fool
Read moreTrump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients
08/01 11:13 am
Benzinga
Read moreTesticular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer
08/01 04:51 am
GlobeNewswire Inc.
Read moreNovo Nordisk: Is the Ozempic Hype Train Finally Slowing Down?
07/31 11:34 am
Investing.com
Read moreEli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health
07/31 09:30 am
Benzinga
Read moreWhy Eli Lilly Stock Was Looking Sickly Today
07/29 06:06 pm
The Motley Fool
Read moreLipoVive Releases Ingredient Report Comparing Natural GLP-1 Support to Synthetic Drugs Like Mounjaro
07/29 05:52 pm
GlobeNewswire Inc.
Read moreNovo Nordisk: Why Is the Stock Falling Over 20% Today?
07/29 09:48 am
Investing.com
Read moreTherini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease
07/29 08:00 am
GlobeNewswire Inc.
Read moreCould GLP-1 Drugs Potentially Help Treat Cancer? 1 Promising Study Suggests They Might
07/26 09:16 am
The Motley Fool
Read moreCongress Sounds Alarm Over Illegal Weight-Loss Drug Imports From China
07/25 02:32 pm
Benzinga
Read moreA New Obesity Contender From China Targeting Same Receptors As Eli Lilly's Blockbuster
07/24 11:21 am
Benzinga
Read moreThe 3 Things That Matter for Eli Lilly Now
07/24 10:15 am
The Motley Fool
Read moreRoche receives CE Mark for minimally invasive blood test to help rule out Alzheimer’s disease
07/23 01:10 am
GlobeNewswire Inc.
Read moreBetter Growth Buy: Eli Lilly vs. Viking Therapeutics
07/22 07:15 am
The Motley Fool
Read moreAquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer
07/22 07:00 am
GlobeNewswire Inc.
Read more3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results
07/22 04:14 am
The Motley Fool
Read more2 Undervalued Healthcare Stocks Poised to Dominate the Next Decade
07/21 08:15 am
The Motley Fool
Read moreAfter Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
07/19 06:09 am
The Motley Fool
Read morePfizer Faces $1 Billion IRA Reform Hit As Analysts Expect Flat 2025 Outlook
07/14 02:39 pm
Benzinga
Read moreGLP-1 Agonists Drug Pipeline Analysis Market Report 2025 | Next-generation GLP-1 Agonists Pave the Way for Diabetes and Obesity Management
07/14 05:56 am
GlobeNewswire Inc.
Read more3 Reasons I Bought Novo Nordisk Stock Instead of Eli Lilly
07/09 06:16 pm
The Motley Fool
Read moreDon’t Miss Out: 3 Blue-Chips Set to Pop This Earnings Season
07/09 07:10 am
Investing.com
Read moreAlzheimer’s Therapeutics Market on Upward Trajectory Across the 7MM During the Forecast Period (2025–2034) Fueled by Drug Development Advances | DelveInsight
07/08 01:00 pm
GlobeNewswire Inc.
Read more2 Dividend Growth Stocks to Buy and Hold Forever
07/06 07:05 am
The Motley Fool
Read more